Quanterix Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
QTRX Nasdaq 2830 www.quanterix.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Quanterix Corporation

ALZpath and Quanterix Expand Strategic Licensing Agreement to Advance Next Generation Alzheimer's Disease Biomarker Research - Oct 7th, 2026 6:30 am
/C O R R E C T I O N -- ALZpath, Inc./ - Oct 7th, 2026 6:30 am
Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration Approvals - Oct 7th, 2026 6:00 am
Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026 - Sep 25th, 2026 6:00 am
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 16th, 2026 7:00 pm
Quanterix Names Dr. Yuri Fesko Chief Medical Officer - Sep 14th, 2026 6:00 am
Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share - Sep 4th, 2026 3:48 am
Quanterix (QTRX) Q2 2026 Earnings Call Transcript - Aug 17th, 2026 10:28 am
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test - Aug 16th, 2026 12:02 pm
Quanterix (QTRX) Earnings Shake Up The Story As Fair Value Still Sits Higher - Aug 12th, 2026 7:13 am
Quanterix Corp (QTRX) (Q2 2026) Earnings Call Highlights: Revenue Miss and Guidance Cut Amid ... - Aug 10th, 2026 3:01 pm
Quanterix Cuts 2026 Revenue Outlook as Commercial Challenges Delay Cash-Flow Break-Even - Aug 10th, 2026 9:04 am
Quanterix Q2 Earnings Call Highlights - Aug 10th, 2026 9:04 am
Quanterix Names Jim Gute Chief Commercial Officer - Aug 10th, 2026 6:01 am
Quanterix Releases Financial Results for the Second Quarter of 2026 - Aug 10th, 2026 6:00 am
Quanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12 - Aug 6th, 2026 6:00 am
Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026 - Aug 4th, 2026 6:00 am
Biomarker Collaboration and Licensing Deals Report 2016-2026 - Featuring Quanterix, Caris Life Sciences, Alnylam Pharmaceuticals, Guardant Health, Eurofins Scientific and More - Jul 21st, 2026 10:28 am
Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Jul 16th, 2026 2:05 pm